International Stem Cell CORP 4
4 · International Stem Cell CORP · Filed Jun 1, 2017
Insider Transaction Report
Form 4
International Stem Cell CORPISCO.OB
Semechkin Andrei
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2017-05-31−70,000→ 70,000 totalExercise: $1.10Exp: 2027-05-31→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]3/36th of the shares underlying such options shall vest on August 31, 2017, and the remaining share in equal monthly installments over a period of 33 months.